| |
Istanbul, September 2008
Turin, May 2007
| “I didn’t realise until the
Turin training exactly what HIVTRI is trying to do—reach out
to doctors with very little support and training who really need
it. I was impressed and pleased to see so many Iraqis in the audience.”
Marta Boffito, UK, training co-chair, (Turin training,
May 2007)
HIV Pharmaco update: Turin 2007
10–11 May 2007, Torino Incontra conference centre,
Turin, Italy
Co-Chairs: Prof Giovanni Di Perri and Dr Marta Boffito
training | programme | trainers | presentations | photos | summary
 David
Back , United Kingdom
David Back is a Professor of Pharmacology at the
University of Liverpool and established the Liverpool HIV Pharmacology
Group (LHPG) in 1987. The Liverpool Group have been at the forefront
of pharmacological research of antiretroviral drugs. Currently there
are numerous ongoing pharmacokinetic (TDM, IQ, drug-drug interaction,
pharmacological mechanisms of resistance) and pharmacogenomic (phenotype-genotype)
studies involving local, national and international collaborations.
They also run the highly successful web site www.hiv-druginteractions.org
and have recently joined with colleagues in Vanderbilt and Lausanne
to launch www.hiv-pharmacogenomics.org. David has authored or co-authored
more than 350 publications and is a former editor of British Journal
of Clinical Pharmacology.
TOP OF PAGE
 Sanjay
Bhagani, United Kingdom
Dr Bhagani is a Consultant Physician in Infectious
Diseases and HIV Medicine at the Royal Free Hospital. He has a special
interest in HIV/hepatitis co-infections and runs a large multidisciplinary
HIV/ hepatitis co-infection service at the Royal Free Hospital.
He has been involved in a study of viral relationships and risk-factors
for the recent epidemic of acute HCV in HIV-positive gay men in
the UK.
TOP OF PAGE
Marta Boffito, Italy
Dr Boffito graduated from the University of Turin,
Turin, Italy in Medicine in 1996. She trained in general medicine
and infectious diseases at the University of Turin and at the University
of California at San Francisco, California, USA (with the Department
of HIV at the General Hospital) and became a specialist in Infectious
Diseases/HIV in 2001. Her HIV-related research was focused on antiretroviral
therapies and AIDS-related lymphoma. She obtained her PhD in 2004
at the University of Liverpool, Liverpool, UK (Department of Pharmacology
and Therapeutics, Prof. DJ Back) with a thesis entitled “Clinical
Pharmacology of Human Immunodeficiency Virus-1 Protease Inhibitors”
which covered the pharmacokinetics and pharmacodynamics of antiretroviral
therapy for HIV. Currently, she is the Associate Director of the
Pharmacokinetic Research Unit at Chelsea and Westminster Hospital,
London, where, in addition to her clinical duties, she is heavily
involved in numerous clinical studies.
TOP OF PAGE
 Martin
Fisher, United Kingdom
Martin Fisher is a Consultant in HIV at Brighton
and Sussex University Hospitals NHS Trust. He is responsible for
the outpatient and inpatient management of a large cohort of HIV
infected individuals, leads an active research team, and has established
an HIV/hepatitis co-infection clinic with local hepatologists. He
is an executive committee member of the British HIV Association,
a member of the HIV Special Interest Group of the British Association
for Sexual Health and HIV, and is the Convenor of the national Diploma
in HIV Medicine. His main clinical and research interests are in
antiretroviral therapy, primary HIV infection, HIV and hepatitis
co-infection, and the interplay between HIV and other sexually transmitted
infections.
TOP OF PAGE
 Anna
Maria Geretti, United Kingdom
Dr Anna Maria Geretti is a Consultant Medical Virologist
and Honorary Senior Lecturer at the Royal Free Hospital in London,
where she heads the Retrovirology laboratory and also works as a
physician with a specialist interest in HIV medicine, viral hepatitis
and genital herpes. She trained in Italy, the Netherlands and the
UK, and holds an MD in Medicine and a PhD in the virology and immunology
of HIV infection. She is an executive member of the British HIV
Association (BHIVA) Executive Committee and contributes to the production
of the BHIVA Treatment Guidelines. She is an advisor to the British
National Formulary and editor of the Journal of Antimicrobial Chemotherapy
and the Journal of HIV Therapy.
TOP OF PAGE
 Tabitha
Mahungu, United Kingdom
Tabitha Mahungu is a Clinical Research Fellow based
at the Department of HIV Medicine at the Royal Free and University
College Medical School. She is currently working towards a PHD in
The Pharmacogenomics of HIV Therapy in collaboration with the Department
of Pharmacology and Therapeutics at the University of Liverpool.
She is involved in various clinical trials in her department and
has presented at national and international conferences.
TOP OF PAGE
 Giovanni
Di Perri, Italy
Giovanni Di Perri is Professor of Infectious Diseases
at the University of Turin, Italy, and is Director of both the Clinical
Department of Infectious Diseases at the University Hospital ‘Amedeo
di Savoia’ in Turin and the Division of Infectious Diseases
at the University of Turin. Professor Di Perri is also Director
of the Postgraduate School of Infectious Diseases at the university.
In 1995, Professor Di Perri was appointed by the World Health Organization
as an external advisor on both HIV-associated tuberculosis and malaria.
He has authored and co-authored more than 130 peer-reviewed articles
on subjects including tuberculosis, HIV infection, malaria, viral
hepatitis and bacterial infections.
TOP OF PAGE
 Laura
Waters, United Kingdom
Dr Laura Waters is a Research Fellow at The St
Stephen’s Centre, Chelsea & Westminster Hospital, London,
UK. She recently completed her Specialist Registrar training in
Genitourinary Medicine at Chelsea & Westminster. Dr Waters works
on antiretroviral pharmacokinetic studies and works and a variety
of Phase 3 clinical trials. She is currently leading a project assessing
the utility of different viral load assays in resource poor settings.
Dr Waters has published several articles in peer-reviewed journals
on a variety of HIV- and GU-related topics and has presented at
national and international scientific conferences.
TOP OF PAGE
 Mike
Youle, B Med Sci, MB ChB,
United Kingdom
After qualifying at Sheffield Medical School, UK,
Dr Mike Youle helped found the world-renowned Kobler Clinic in London
in 1986 as Clinical Trials Co-ordinator. Other than a 1-year stint
working as a Consultant for the World Health Organization’s
Global Programme on AIDS and the National Programme on AIDS in Kampala,
Dr Youle has devoted most of his career to the clinical care of
HIV patients. Since 1996 he has been the Director of HIV Clinical
Research at London’s Royal Free Hospital as well as an Honorary
Senior Lecturer in Public Health at its associated medical school.
His numerous professional activities currently include a visiting
professorship for Belgrade University and board/committee memberships
for organizations such as the International Association of Physicians
in AIDS Care, the British HIV Association and the MANON Therapeutic
Vaccine Programme. Dr Youle also serves as a trustee of the Red
Hot AIDS Charitable Trust and the National AIDS Manual, as well
as medical advisor to the Elton John AIDS Foundation.
TOP OF PAGE
|
